Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-Term Experience with Hyperthermic Chemotherapy (HIVEC) Using Mitomycin-C in Patients with Non-Muscle Invasive Bladder Cancer in Spain.
Plata A, Guerrero-Ramos F, Garcia C, González-Díaz A, Gonzalez-Valcárcel I, de la Morena JM, Díaz-Goizueta FJ, Del Álamo JF, Gonzalo V, Montero J, Sousa-Escandón A, León J, Pontones JL, Delgado F, Adriazola M, Pascual Á, Calleja J, Ruano A, Martínez-Piñeiro L, Angulo JC. Plata A, et al. J Clin Med. 2021 Oct 30;10(21):5105. doi: 10.3390/jcm10215105. J Clin Med. 2021. PMID: 34768625 Free PMC article.
Reply by Authors.
Tyson MD, Morris D, Palou J, Rodriguez O, Mir MC, Dickstein RJ, Guerrero-Ramos F, Scarpato KR, Hafron JM, Messing EM, Cutie CJ, Maffeo JC, Raybold B, Chau A, Stromberg KA, Keegan KA. Tyson MD, et al. Among authors: guerrero ramos f. J Urol. 2023 May;209(5):900. doi: 10.1097/JU.0000000000003195.02. Epub 2023 Apr 7. J Urol. 2023. PMID: 37026638 No abstract available.
Quality of life and adverse events in patients with nonmuscle invasive bladder cancer receiving adjuvant treatment with BCG, MMC, or chemohyperthermia.
González-Padilla DA, González-Díaz A, Guerrero-Ramos F, Rodríguez-Serrano A, García-Jarabo E, Corona-laPuerta M, Rodríguez-Antolín A, Villacampa-Aubá F. González-Padilla DA, et al. Urol Oncol. 2021 Jan;39(1):76.e9-76.e14. doi: 10.1016/j.urolonc.2020.07.003. Epub 2020 Aug 1. Urol Oncol. 2021. PMID: 32753359
Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
Zhao H, Chan VW, Castellani D, Chan EO, Ong WLK, Peng Q, Moschini M, Krajewski W, Pradere B, Ng CF, Enikeev D, Vasdev N, Ekin G, Sousa A, Leon J, Guerrero-Ramos F, Tan WS, Kelly J, Shariat SF, Witjes JA, Teoh JY. Zhao H, et al. Front Surg. 2021 Nov 23;8:775527. doi: 10.3389/fsurg.2021.775527. eCollection 2021. Front Surg. 2021. PMID: 34888347 Free PMC article.
Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial.
Guerrero-Ramos F, González-Padilla DA, González-Díaz A, de la Rosa-Kehrmann F, Rodríguez-Antolín A, Inman BA, Villacampa-Aubá F. Guerrero-Ramos F, et al. World J Urol. 2022 Apr;40(4):999-1004. doi: 10.1007/s00345-022-03928-1. Epub 2022 Jan 17. World J Urol. 2022. PMID: 35037963 Free PMC article. Clinical Trial.
Mitomycin C allergy after passive and device-assisted hyperthermia for non-muscle invasive bladder cancer treatment: A retrospective cohort from a high-volume center.
González-Padilla DA, Subiela JD, González-Díaz A, Hernández-Arroyo M, García-Rojo E, Aumatell J, Burgos Revilla J, Rodríguez-Antolín A, Guerrero-Ramos F. González-Padilla DA, et al. Urol Oncol. 2022 Jul;40(7):345.e19-345.e23. doi: 10.1016/j.urolonc.2022.02.018. Epub 2022 Apr 14. Urol Oncol. 2022. PMID: 35430137
Corrigendum to <'Mitomycin C allergy after passive and device-assisted hyperthermia for non-muscle invasive bladder cancer treatment: A retrospective cohort from a high-volume center'> <[Volume 40, Issue 7, July 2022, Pages 345.e19-345.e23]>
González-Padilla DA, Subiela JD, González-Díaz A, Hernández-Arroyo M, García-Rojo E, Aumatell J, Burgos Revilla J, Rodríguez-Antolín A, Guerrero-Ramos F. González-Padilla DA, et al. Urol Oncol. 2022 Oct;40(10):463. doi: 10.1016/j.urolonc.2022.06.017. Epub 2022 Aug 12. Urol Oncol. 2022. PMID: 35970697 No abstract available.
[Mitomycin C HIVEC. Update and results in high risk patients.].
Guerrero-Ramos F, Castellano-Gauna D, García-Rojo E, Duarte-Ojeda JM, de la Rosa-Kehrmann F, Villacampa-Aubá F. Guerrero-Ramos F, et al. Arch Esp Urol. 2018 May;71(4):417-425. Arch Esp Urol. 2018. PMID: 29745931 Free article. Review. Spanish.
Evaluation of health care-associated infections following radical cystectomy.
García-Rojo E, Medina-Polo J, Miranda-Utrera N, Abad-López P, Gonzalez-Padilla DA, González-Díaz A, Arrébola-Pajares A, Guerrero-Ramos F, Tejido-Sánchez Á, Rodríguez-Antolín A. García-Rojo E, et al. Actas Urol Esp (Engl Ed). 2021 Mar;45(2):124-131. doi: 10.1016/j.acuro.2020.06.004. Epub 2020 Sep 15. Actas Urol Esp (Engl Ed). 2021. PMID: 32948346 English, Spanish.
51 results